Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-06-26 @ 8:35 AM
Study NCT ID:
NCT06046794
Status:
RECRUITING
Last Update Posted:
2025-06-11
First Post:
2023-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients
Sponsor:
Institut Paoli-Calmettes
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GemSign-01-IPC 2022-068
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None